BioCryst Pharmaceuticals, Inc. (BCRX)
NGS · Common · CUSIP 09058V103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BCRX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
09058V103
Market Cap
Mid Cap
Business: BioCryst Pharmaceuticals, Inc. is a biotechnology company that designs, optimizes and develops novel small-molecule medicines that address both common and rare conditions.

Company Contact

CEO
Jon P. Stonehouse
CFO
Anthony Doyle
Headquarters
4505 Emperor Blvd., Suite 200, Durham, NC 27703
Phone
919-859-1302
Fax
919-859-1314
Investor Relations
John Bluth · 919-859-7910 · investorrelations@biocryst.com
General Email
info@biocryst.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »